[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. [2] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [3] KOLIOPOULOS G, NYAGA V N, SANTESSO N, et al. Cytology versus HPV testing for cervical cancer screening in the general population[J]. Cochrane Database Syst Rev, 2017, 8(8):CD008587. [4] HOFFMAN S R, LE T, LOCKHART A, et al. Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN):A systematic review[J]. Int J Cancer, 2017, 141(1):8-23. [5] WANG Y Y, WANG S H, SHEN J H, et al. Genotype distribution of human papillomavirus among women with cervical cytological abnormalities or invasive squamous cell carcinoma in a high-incidence area of esophageal carcinoma in China[J]. Biomed Res Int, 2016, 2016:1256384. [6] LI K M, LI Q L, SONG L, et al. The distribution and prevalence of human papillomavirus in women in mainland China[J]. Cancer, 2019, 125(7):1030-1037. [7] WANG R, GUO X L, WISMAN G B, et al. Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China[J]. BMC Infect Dis, 2015, 15:257. [8] NAH E H, CHO S, KIM S, et al. Human papillomavirus genotype distribution among 18, 815 women in 13 Korean cities and relationship with cervical cytology findings[J]. Ann Lab Med, 2017, 37(5):426-433. [9] JING L P, ZHONG X M, HUANG W H, et al. HPV genotypes and associated cervical cytological abnormalities in women from the Pearl River Delta region of Guangdong Province, China:a cross-sectional study[J]. BMC Infect Dis, 2014, 14:388. [10] 冯淑燕, 冯淑玲. 1026例育龄妇女HPV感染情况调查及分析[J]. 中国妇幼保健, 2011, 26(9):1374-1377. [11] 林亚珍, 唐忠辉, 黄仲庆, 等. 漳州地区HPV感染的基因型分布特点与宫颈病变的关系[J]. 山西医科大学学报, 2014, 45(12):1147-1150. [12] BRUNI L, DIAZ M, FERRER E, et al. Cervical human papillomavirus prevalence in 5 continents:meta-analysis of 1 million women with normal cytological findings[J]. J Infect Dis, 2010, 202(12):1789-1799. [13] SO K A, LEE I H, LEE K H, et al. Human papillomavirus genotype-specific risk in cervical carcinogenesis[J]. J Gynecol Oncol, 2019, 30(4):52. |